While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...
For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...
5d
News-Medical.Net on MSNGLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
Research shows that people on GLP-1 medications are ditching processed foods and buying more nutrient-dense ones like fresh produce, beans and yogurt. (Photo illustrations: Yahoo News; photos ...
A recent study suggests that GLP-1 receptor agonists (GLP-1RAs) may lower the risk of hematologic cancers, including leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results